Bad, CA), using the destination vectors pDEST-527, pDEST-565 (Protein Expression Laboratory

Bad, CA), using the destination vectors pDEST-527, pDEST-565 (Protein Expression Laboratory, SAIC-Frederick, Frederick, MD, USA) and pDEST-HisMBP [18]. The standard LR reaction was Lecirelin employed throughout as per the manufacturer’s protocol. A two-step PCR procedure was used to construct Gateway entry clones of the passenger proteins. The open reading frames or entry clones encoding green fluorescent protein (GFP) [4], glyceraldehyde 3phosphate dehydrogenase (G3PDH) [6], dihydrofolate reductase (DHFR) [6], dual specificity phosphatase 14 (DUSP14) [19], and tobacco etch virus (TEV) protease [20] were described previously. In each case, a pair of gene-specific primers was utilized in a PCR reaction with the appropriate plasmid template and then the PCR amplicon from this reaction was used as the template for a second round of PCR with the forward primer PE-277 (59-GGGG ACA AGT TTG TAC AAA AAA GCA GGC TCG GAG AAC CTG TAC TTC 1326631 CAG-39) and the gene-specific reverse primer (Table 1). The final PCR amplicons were recombined into pDONR221 (Life Technologies) to generate the entry clones, except for GFP and G3PDH, which were recombined into pDONR201 (Life Technologies) instead. All of the entry clones were subsequently recombined in LR reactions with the destination vectors mentioned above. The resulting protein expression vectors encoded either His6- (pDEST-527 in the LR reaction), His6-GST (pDEST-565 in the LR reaction), or His6-MBP (pDEST-HisMBP in the LR reaction) tags appended to the Ntermini of the passenger proteins along with canonical TEV protease recognition sites (ENLYFQG) between the tags and the passengers (except for the vectors encoding TEV protease fusions, which contained the uncleavable recognition site ENLYFQP [21] instead). The pDEST-HisMBP derivative carrying an I329W mutation in MBP was constructed with a QuikChange SiteDirected Mutagenesis Kit (Agilent Technologies Inc., Santa Clara, CA). The nucleotide sequences of all vectors were confirmed experimentally. GroEL/S plasmids used in co-expression and interaction studies were obtained from Jonathan Weissman’s laboratory [22].DH5a cells as described previously [22] with slight modifications. In brief, the His6-MBP-GFP expression vector and pJDW66 (or its derivative encoding the GFP-optimized GroEL/S variant 3?, pJDW67) were co-transformed into E. coli. A single fresh colony was inoculated into LB broth with appropriate antibiotic(s) and grown at 37uC. His6-MBP-GFP expression was induced in log phase cultures (OD600 = 0.2?.4) by the addition of IPTG to 1 mM. The cells were harvested after 3 h, resuspended in 50 mM Tris-HCl (pH 7.6), 1 mM EDTA and disrupted by sonication. The cells expressing His6-MBP-GFP and GroEwt (or GroE3?) were normalized by final cell OD600, illuminated under blue light (fluorescence) or visible light and photographed. POR 8 chemical information Samples of the total and soluble intracellular protein for SDS-PAGE were extracted from these normalized cell suspensions and the gels were stained with Coomassie brilliant blue R-350. Wild-type or otherwise isogenic single gene knockout mutants of E. coli K-12 (DdnaK, DdnaJ, Dtig) [23,24] were used for expression studies involving His6-MBP-G3PDH and His6-MBP-DHFR, which were performed as described above. Immunoblotting was carried out using standard procedures with anti-Histag (Abcam, Cambridge, MA) or anti-GroEL (SigmaAldrich, St. Louis, MO) primary antibodies and alkaline phosphatase (AP)-conjugated secondary antibodies (KPL, Gaithersburg, MD.Bad, CA), using the destination vectors pDEST-527, pDEST-565 (Protein Expression Laboratory, SAIC-Frederick, Frederick, MD, USA) and pDEST-HisMBP [18]. The standard LR reaction was employed throughout as per the manufacturer’s protocol. A two-step PCR procedure was used to construct Gateway entry clones of the passenger proteins. The open reading frames or entry clones encoding green fluorescent protein (GFP) [4], glyceraldehyde 3phosphate dehydrogenase (G3PDH) [6], dihydrofolate reductase (DHFR) [6], dual specificity phosphatase 14 (DUSP14) [19], and tobacco etch virus (TEV) protease [20] were described previously. In each case, a pair of gene-specific primers was utilized in a PCR reaction with the appropriate plasmid template and then the PCR amplicon from this reaction was used as the template for a second round of PCR with the forward primer PE-277 (59-GGGG ACA AGT TTG TAC AAA AAA GCA GGC TCG GAG AAC CTG TAC TTC 1326631 CAG-39) and the gene-specific reverse primer (Table 1). The final PCR amplicons were recombined into pDONR221 (Life Technologies) to generate the entry clones, except for GFP and G3PDH, which were recombined into pDONR201 (Life Technologies) instead. All of the entry clones were subsequently recombined in LR reactions with the destination vectors mentioned above. The resulting protein expression vectors encoded either His6- (pDEST-527 in the LR reaction), His6-GST (pDEST-565 in the LR reaction), or His6-MBP (pDEST-HisMBP in the LR reaction) tags appended to the Ntermini of the passenger proteins along with canonical TEV protease recognition sites (ENLYFQG) between the tags and the passengers (except for the vectors encoding TEV protease fusions, which contained the uncleavable recognition site ENLYFQP [21] instead). The pDEST-HisMBP derivative carrying an I329W mutation in MBP was constructed with a QuikChange SiteDirected Mutagenesis Kit (Agilent Technologies Inc., Santa Clara, CA). The nucleotide sequences of all vectors were confirmed experimentally. GroEL/S plasmids used in co-expression and interaction studies were obtained from Jonathan Weissman’s laboratory [22].DH5a cells as described previously [22] with slight modifications. In brief, the His6-MBP-GFP expression vector and pJDW66 (or its derivative encoding the GFP-optimized GroEL/S variant 3?, pJDW67) were co-transformed into E. coli. A single fresh colony was inoculated into LB broth with appropriate antibiotic(s) and grown at 37uC. His6-MBP-GFP expression was induced in log phase cultures (OD600 = 0.2?.4) by the addition of IPTG to 1 mM. The cells were harvested after 3 h, resuspended in 50 mM Tris-HCl (pH 7.6), 1 mM EDTA and disrupted by sonication. The cells expressing His6-MBP-GFP and GroEwt (or GroE3?) were normalized by final cell OD600, illuminated under blue light (fluorescence) or visible light and photographed. Samples of the total and soluble intracellular protein for SDS-PAGE were extracted from these normalized cell suspensions and the gels were stained with Coomassie brilliant blue R-350. Wild-type or otherwise isogenic single gene knockout mutants of E. coli K-12 (DdnaK, DdnaJ, Dtig) [23,24] were used for expression studies involving His6-MBP-G3PDH and His6-MBP-DHFR, which were performed as described above. Immunoblotting was carried out using standard procedures with anti-Histag (Abcam, Cambridge, MA) or anti-GroEL (SigmaAldrich, St. Louis, MO) primary antibodies and alkaline phosphatase (AP)-conjugated secondary antibodies (KPL, Gaithersburg, MD.